caretrace.iopowered by▸healthparse
SearchCohort Builder
Tools▾
KOL FinderTerritoriesDrug Compare
AI Query
Browse▾
By stateBy specialty
Pricing
SearchCohort BuilderToolsKOL FinderTerritoriesDrug CompareAI QueryBrowseBy stateBy specialtyPricing
PROVIDER PROFILE · NPI 1578650818

Danielle PattersonMD

Obstetrics & GynecologyBaltimore, MDI
CROSS-REFERENCE

Related data on other Healthparse brands

ProviderScore
OIG/SAM exclusion screening, sanctions history
© 2026 CareTrace
PricingContactPrivacyTerms
REFERRAL NETWORK

Where Danielle Patterson's patients come from & go

Directional shared-patient flow from Medicare claims — who sends patients to this provider (inbound) and where this provider's patients go next (outbound). 1 inbound referrers · 0 outbound destinations.

Receives referrals from
Inbound — who sends patients here
PhysicianPatientsVisits
Deborah Carr
Nurse Practitioner · Boston, MA
2240
Refers patients to
Outbound — where patients go next
No outbound pairs above the suppression threshold.
Source: CMS Physician Shared Patient Patterns (30-day window, Medicare FFS). Direction = a beneficiary seen by the first provider, then the second, within 30 days; a proxy for referral, not a documented referral. Pairs with fewer than 11 shared beneficiaries are suppressed.
MEDICARE UTILIZATION · PART B · 2024
Total beneficiaries
541
Unique beneficiaries
—
Total services
603
Distinct HCPCS
13
Medicare payment
$42K
Peer benchmark
Q1
Q2
Q3
Q4
Q5
Total Medicare services vs. 503 Obstetrics & Gynecology providers in MD — top quintile (cohort median 133).
PRESCRIBING · PART D · 2024
Total Rx claims
283
Beneficiaries
—
Total drug cost
$74K
Distinct drugs
5
Brand share
38.9%
Top prescribed drugs
Estradiol173 claims
Mirabegron47 claims
Nitrofurantoin Monohyd/M-Cryst18 claims
Estradiol17 claims
Vibegron14 claims
QUALITY · MIPS · 2024
Final MIPS score
83.3
Quality
73.9
Cost
70.5
Improvement activities
40.0
Promoting interop.
100.0
Payment adjustment
0.35%
Group
INDUSTRY PAYMENTS · OPEN PAYMENTS · 2024
No data available for this provider in 2024.